{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:40:20Z","timestamp":1789717220838,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["and SAF2014-52374-R"],"award-info":[{"award-number":["and SAF2014-52374-R"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alianza VHL Spain","award":["no number ONG"],"award-info":[{"award-number":["no number ONG"]}]},{"name":"Fundaci\u00f3n Iberdrola","award":["no number private award"],"award-info":[{"award-number":["no number private award"]}]},{"name":"Bodegas Protos","award":["private award"],"award-info":[{"award-number":["private award"]}]},{"name":"CIBERER IS CARLOS III SPAIN","award":["U-707"],"award-info":[{"award-number":["U-707"]}]},{"name":"FUNDACI\u00d3N PORT AVENTURA","award":["PRIVATE AWARD"],"award-info":[{"award-number":["PRIVATE AWARD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0664-7","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T07:34:24Z","timestamp":1498721664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Virginia","family":"Albi\u00f1ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Mar\u00eda Jim\u00e9nez","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Rodr\u00edguez","family":"Padial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Recio-Poveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Villar G\u00f3mez de las Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Mar\u00eda","family":"Botella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"664_CR1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"283","author":"ER Maher","year":"1990","unstructured":"Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Moore AT, et al. Clinical Features and Natural History of von Hippel-Lindau Disease. Q J Med. 1990;283:1151\u201363.","journal-title":"Q J Med"},{"key":"664_CR2","doi-asserted-by":"crossref","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. Von Hippel-Lindau disease. Lancet. 2003:2059\u201367.","DOI":"10.1016\/S0140-6736(03)13643-4"},{"issue":"11","key":"664_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.oftal.2011.10.005","volume":"87","author":"AB Gonz\u00e1lez Escobar","year":"2012","unstructured":"Gonz\u00e1lez Escobar AB, Morillo S\u00e1nchez MJ, Garc\u00eda-Campos JM. Enfermedad de Von Hippel Lindau: estudio familiar. Arch Soc Esp Oftalmol. 2012;87(11):368\u201372.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"664_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","volume":"23","author":"S Richard","year":"2013","unstructured":"Richard S, Gardie B, Couv\u00e8 S, Von Hippel-Lindau GS. How a rare disease illuminates cancer biology. Semin Cancer Biol. 2013;23:26\u201337.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"664_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.iae.0000244659.62202.ee","volume":"27","author":"CC Chan","year":"2007","unstructured":"Chan CC, Collins ABDCE. molecular pathology of eyes with von hippel\u2013lindau (vhl) disease a review. Retina. 2007;27(1):1\u20137.","journal-title":"Retina"},{"key":"664_CR6","doi-asserted-by":"crossref","unstructured":"Maher ER, Neumann HP, Richard S. von Hippel\u2013Lindau disease: A clinical and scientific review. Eur J Hum Genet. 2011;19(6):617\u201323. Available from: http:\/\/www.nature.com\/ejhg\/journal\/v19\/n6\/full\/ejhg2010175a .","DOI":"10.1038\/ejhg.2010.175"},{"key":"664_CR7","unstructured":"Chew EY. Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans Am Ophthalmol Soc. 2005;103:495\u2013511. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=1447586&tool=pmcentrez&rendertype=abstract ."},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/eye.2012.259","volume":"27","author":"V Papastefanou","year":"2013","unstructured":"Papastefanou V, Pilli S, Stinghe A, Lotery AJ, Cohen V. Photodynamic therapy for retinal capillary hemangioma. Eye. 2013;27:438\u201342. doi: 10.1038\/eye.2012.259 .","journal-title":"Eye"},{"issue":"2","key":"664_CR9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pdpdt.2014.02.013","volume":"11","author":"Y Chen","year":"2014","unstructured":"Chen Y, Liu H, Zhang K, Gao L. Massive exudative retinal detachment following photodynamic therapy for retinal hemangioma in von Hippel-Lindau Syndrome. Photodiagn Photodyn Ther. 2014;11(2):250\u20133.","journal-title":"Photodiagn Photodyn Ther"},{"key":"664_CR10","doi-asserted-by":"crossref","unstructured":"Tsai F-Y, Lau L-I, Chen S-J, Lee F-L, Lee S-M. Persistent exudative retinal detachment after photodynamic therapy and intravitreal bevacizumab injection for multiple retinal capillary hemangiomas in a patient with von Hippel-Lindau disease. J Chin Med Assoc. 2014 Jan 1 [cited 2017 Feb 5];77(1):52\u20136. Available from: http:\/\/www.jcma-online.com\/article\/S172649011300244X\/fulltext .","DOI":"10.1016\/j.jcma.2013.09.001"},{"issue":"4","key":"664_CR11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.pdpdt.2015.10.008","volume":"12","author":"RN Hussain","year":"2015","unstructured":"Hussain RN, Jmor F, Damato B, Heimann H. Verteporfin photodynamic therapy for the treatment of sporadic retinal capillary haemangioblastoma. Photodiagn Photodyn Ther. 2015;12(4):555\u201360.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"3","key":"664_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/0378-6323.51238","volume":"75","author":"K HM","year":"2009","unstructured":"HM K, KH P. Massive Exudative Retinal Detachment Following Photodynamic Therapy and Intravitreal Bevacizumab Injection in Retinal Capillary Hemangioma. Indian J Dermatol Venereol Leprol. 2009;75(3):225\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9917727 .","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"664_CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0420.2006.00825.x","volume":"85","author":"M Buelow von","year":"2007","unstructured":"von Buelow M, Pape S, Hoerauf H. Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma. Acta Ophthalmol Scand. 2007;85(1):114\u20136.","journal-title":"Acta Ophthalmol Scand"},{"key":"664_CR14","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1111\/j.1755-3768.2009.01611.x","volume":"88","author":"W Wackernagel","year":"2010","unstructured":"Wackernagel W, Lackner E-M, Pilz S, Mayer C, Stepan V. von Hippel-Lindau disease: treatment of retinal haemangioblastomas by targeted therapy with systemic bevacizumab. Acta Ophthalmol. 2010;88:e271\u20132.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"664_CR15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcjo.2014.07.007","volume":"49","author":"E Slim","year":"2014","unstructured":"Slim E, Antoun J, Kourie HR, Schakkal A, Cherfan G. Intravitreal bevacizumab for retinal capillary haemangioblastoma: A case series and literature review. Can J Ophthalmol. 2014;49(5):450\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25284102 .","journal-title":"Can J Ophthalmol"},{"key":"664_CR16","doi-asserted-by":"crossref","unstructured":"Wong WT, Liang KJ, Hammel K, Coleman HR, Chew EY. Intravitreal ranibizumab therapy for retinal capillary haemangioblastoma related to von Hippel-Lindau disease. Ophthalmology. 2008 Nov 1 [cited 2017 Feb 5];115(11):1957\u201364. Available from: http:\/\/www.aaojournal.org\/article\/S0161642008004211\/fulltext .","DOI":"10.1016\/j.ophtha.2008.04.033"},{"issue":"8","key":"664_CR17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00417-014-2660-0","volume":"252","author":"Y Wang","year":"2014","unstructured":"Wang Y, Abu-Asab MS, Shen D, Zhuang Z, Chew EY, Chan CC. Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal haemangioblastoma. Graefes Arch Clin Exp Ophthalmol. 2014;252(8):1319\u201327.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"664_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","volume":"163","author":"CH Storch","year":"2010","unstructured":"Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action. Br J Dermatol. 2010;163:269\u201374.","journal-title":"Br J Dermatol"},{"issue":"1","key":"664_CR19","doi-asserted-by":"crossref","first-page":"a006460","DOI":"10.1101\/cshperspect.a006460","volume":"1","author":"S Greenberger","year":"2011","unstructured":"Greenberger S, Bischoff J. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. Cold Spring Harb Perspect Med. 2011;1(1):a006460.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"664_CR20","doi-asserted-by":"crossref","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo J-B, Ta\u00efeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358(24):2649\u201351. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20117846 .","DOI":"10.1056\/NEJMc0708819"},{"key":"664_CR21","doi-asserted-by":"crossref","unstructured":"Powe DG, Voss MJ, Z\u00e4nker KS, Habashy HO, Green AR, Ellis IO, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010;1(7):628\u201338. Available from: www.impactjournals.com\/oncotarget .","DOI":"10.18632\/oncotarget.197"},{"issue":"10","key":"664_CR22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.18632\/oncotarget.343","volume":"2","author":"E Pasquier","year":"2011","unstructured":"Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. 2011;2(10):797\u2013809. Available from: www.impactjournals.com\/oncotarget","journal-title":"Oncotarget"},{"key":"664_CR23","doi-asserted-by":"crossref","unstructured":"Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: A population-based study. J Clin Oncol. 2011;","DOI":"10.1200\/JCO.2010.33.5422"},{"issue":"2","key":"664_CR24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10549-011-1505-3","volume":"129","author":"PA Ganz","year":"2012","unstructured":"Ganz PA, Habel LA, Weltzien EK, Caan BJCS. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: Results from the LACE cohort. Breast Cancer Res Treat. 2012;129(2):549\u201356.","journal-title":"Breast Cancer Res Treat"},{"key":"664_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijporl.2011.01.028","volume":"75","author":"S Peridis","year":"2011","unstructured":"Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K. A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol. 2011;75:455\u201360.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"664_CR26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-0031-1291300","volume":"22","author":"S Hernandez-Martin","year":"2012","unstructured":"Hernandez-Martin S, Lopez-Gutierrez JC, Lopez-Fernandez S, Ramrez M, Miguel M, Coya J, et al. Brain perfusion SPECT in patients with PHACES syndrome under propranolol treatment. Eur J Pediatr Surg. 2012;22:54\u20139.","journal-title":"Eur J Pediatr Surg"},{"key":"664_CR27","doi-asserted-by":"publisher","unstructured":"Alexiou GA, Moschovi M, Prodromou N. Letter to the Editor: Pediatric cavernomas. J Neurosurg Pediatr 2012;10(3):252. Available from: doi: 10.3171\/2011.12.PEDS11503","DOI":"10.3171\/2011.12.PEDS11503"},{"issue":"2","key":"664_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0009922813492885","volume":"53","author":"I Berti","year":"2014","unstructured":"Berti I, Marchetti F, Skabar A, Zennaro F, Zanon DVA. Propranolol for cerebral cavernous angiomatosis: A magic bullet. Clin Pediatr (Phila). 2014;53(2):189\u201390.","journal-title":"Clin Pediatr (Phila)"},{"key":"664_CR29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.wneu.2015.11.003","volume":"88","author":"JM Zabramski","year":"2016","unstructured":"Zabramski JM, Kalani MYS, Filippidis AS, Spetzler RF. Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage. World Neurosurg. 2016;88:631\u20139.","journal-title":"World Neurosurg"},{"issue":"6","key":"664_CR30","doi-asserted-by":"crossref","first-page":"922","DOI":"10.5301\/ejo.5000322","volume":"23","author":"R Thapa","year":"2013","unstructured":"Thapa R, Shields CL. Oral propranolol therapy for management of exudative retinal detachment from diffuse choroidal hemangioma in Sturge-Weber syndrome. Eur J Ophthalmol. 2013;23(6):922\u20134.","journal-title":"Eur J Ophthalmol"},{"key":"664_CR31","doi-asserted-by":"crossref","first-page":"H113","DOI":"10.1016\/S0929-693X(12)71167-3","volume":"19","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2012","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C. Le propranolol dans les h\u00e9mangiomes. Arch P\u00e9diatrie. 2012;19:H113\u20134.","journal-title":"Arch P\u00e9diatrie"},{"issue":"3","key":"664_CR32","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2008-3458","volume":"124","author":"V Sans","year":"2009","unstructured":"Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, et al. Propranolol for Severe Infantile Hemangiomas: Follow-Up Report. Pediatrics. 2009;124(3):e423\u201331. Available from: http:\/\/www.pediatrics.aappublications.org\/content\/124\/3\/e423 .","journal-title":"Pediatrics"},{"issue":"5\u20136","key":"664_CR33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.vph.2010.08.002","volume":"53","author":"S Lamy","year":"2010","unstructured":"Lamy S, Lachambre MP, Lord-Dufour S, Beliveau R. Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells. Vasc Pharmacol. 2010;53(5\u20136):200\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20732454 .","journal-title":"Vasc Pharmacol"},{"issue":"1","key":"664_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1160\/TH11-11-0809","volume":"108","author":"V Albi\u00f1ana","year":"2012","unstructured":"Albi\u00f1ana V, Recio-Poveda L, Zarrabeitia R, Bernab\u00e9u C, Botella LM. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia. Thromb Haemost. 2012;108(1):41\u201353.","journal-title":"Thromb Haemost"},{"key":"664_CR35","doi-asserted-by":"crossref","unstructured":"Albi\u00f1ana V, Villar G\u00f3mez de Las Heras K, Serrano-Heras G, Segura T, Perona-Moratalla AB, Mota-P\u00e9rez M, et al. Propranolol reduces viability and induces apoptosis in haemangioblastoma cells from von Hippel-Lindau patients. Orphanet J Rare Dis. 2015;10(1):118. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26394686%5C , http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC4579575 .","DOI":"10.1186\/s13023-015-0343-5"},{"issue":"4","key":"664_CR36","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.3892\/mmr.2015.4170","volume":"12","author":"S Guo","year":"2015","unstructured":"Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang Y, et al. MicroRNA-210 is upregulated by hypoxia-inducible factor-1alpha in the stromal cells of giant cell tumours of bone. Mol Med Rep. 2015;12(4):6185\u201392.","journal-title":"Mol Med Rep"},{"key":"664_CR37","first-page":"1049","volume":"11","author":"S Wizigmann-Voos","year":"1996","unstructured":"Wizigmann-Voos S, Plate KH. Pathology, genetics and cell biology of haemangioblastomas. Histol Histopathol. 1996;11:1049\u201361.","journal-title":"Histol Histopathol"},{"key":"664_CR38","doi-asserted-by":"crossref","unstructured":"Frolov VA, Moiseeva EG. Pasechnik AV, Pathophysiological aspects of functional modulation of human peripheral blood neutrophils with propranolol. Bull Exp Biol Med. 2006;(6):141, 675\u20137.","DOI":"10.1007\/s10517-006-0249-2"},{"key":"664_CR39","doi-asserted-by":"crossref","unstructured":"Munabi NCO, England RW, Edwards AK, Kitajewski AA, Tan QK, Weinstein A, et al. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation. Stem Cells Transl Med. 2016;5(1):45\u201355. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26574555%5C , http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC4704871 .","DOI":"10.5966\/sctm.2015-0076"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T11:49:01Z","timestamp":1569584941000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0664-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]},"article-number":"122"}}